Yes 42 and lower toxicity.
But as usual biotech is always risky, it takes longer than expected (recruitment, etc.)... so I can understand why it's not priced in yet.
To me we're not too far from TLX's fair value which should be around $14 if you ask me, and $18 (as per USB) as soon as 250 is given FDA approval.
Ann: Telix 2023 Full Year Results and Investor Webcast/Call, page-121
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.48 |
Change
0.300(1.65%) |
Mkt cap ! $6.184B | |||
| Open | High | Low | Value | Volume |
| $18.10 | $18.48 | $17.97 | $12.51M | 683.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1888 | $18.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.49 | 3946 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |